mind body system glp 1 Dual-action obesity drug rewires brain circuits for appetite Hunting for heroes: Brain neurons

Burden of Illness in Type 2 Diabetes Mellitus

Food and Nutrition Insecurity Food security and nutrition security may influence efficacy of GLP-1s

Association between different GLP-1 receptor agonists and gastrointestinal adverse reactions: a real-world disproportionality study based on FDA adverse event reporting system database

To overcome these limitations, researchers are developing next-generation oral GLP-1 therapies designed to: According to the Zydus development overview, ZYOG1 is a novel orally administered GLP-1 receptor agonist currently in development for type 2 diabetes and obesity

Exclusive Pharma Industry 4 min read The Expiry of Ozempics Patent in 2026 Could Revolutionize Indias Battle Against Obesity Despite the rising burden of obesity-related illnessesranging from diabetes and cardiovascular diseases to metabolic disorderseffective pharmacological treatments like Ozempic remain out of reach for most Indians due to their prohibitive costs

Over the past year, the short and long basket actually have a decent correlation (0.779) so this could prove to be a good collection for L/S based on this single factor